tiprankstipranks
Advertisement
Advertisement

LEXX Stock Latest News

Lexaria Bioscience extends material transfer agreement with pharma company
The FlyLexaria Bioscience extends material transfer agreement with pharma company
2d ago
LEXX
Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs
PremiumThe Fly
Lexaria Bioscience launches new study to examine next-gen GLP-1 drugs
8d ago
LEXX
Lexaria Bioscience provides update on GLP-1 oral pill market
PremiumThe Fly
Lexaria Bioscience provides update on GLP-1 oral pill market
10d ago
LEXX
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
PremiumCompany Announcements
Lexaria Launches New GLP-1 Study to Expand Drug Delivery IP
16d ago
LEXX
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
PremiumThe Fly
Lexaria Bioscience engages CRO for 2026 GLP-1-A26-1 study
16d ago
LEXX
Lexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
PremiumCompany AnnouncementsLexaria Eyes Growing Oral GLP-1 Market After Eli Lilly’s Foundayo Approval
24d ago
LEXX
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
Premium
The Fly
Lexaria Bioscience ‘applauds’ Eli Lilly’s Foundayo drug approval
24d ago
LLY
LEXX
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
Premium
Company Announcements
Lexaria Launches New Human Trial to Advance Oral GLP-1 Drug Delivery Platform
30d ago
LEXX
Lexaria Bioscience to begin new human clinical study in GLP-1
PremiumThe Fly
Lexaria Bioscience to begin new human clinical study in GLP-1
1M ago
LEXX
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
PremiumCompany Announcements
Lexaria Bolsters Global Patent Portfolio With New GLP-1 and Cardiometabolic IP
1M ago
LEXX
Lexaria receives five new patents, including two for diabetes treatment
PremiumThe Fly
Lexaria receives five new patents, including two for diabetes treatment
1M ago
LEXX
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
PremiumCompany Announcements
Lexaria Targets Booming GLP-1 Market With Enhanced Oral Drug Platform
1M ago
LEXX
Lexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
PremiumCompany AnnouncementsLexaria Launches 2026 R&D Push to Advance GLP-1 and Cannabidiol Drug Delivery
2M ago
LEXX
Lexaria Bioscience announces 2026 R&D plans
Premium
The Fly
Lexaria Bioscience announces 2026 R&D plans
2M ago
LEXX
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
Premium
Company Announcements
Lexaria’s Oral Liraglutide Shows Comparable Performance and Fewer Side Effects in Human Study
3M ago
LEXX
Lexaria announces final results from GLP-1-H25-5 study
PremiumThe Fly
Lexaria announces final results from GLP-1-H25-5 study
3M ago
LEXX
Lexaria Bioscience Shareholders Endorse Directors and Auditors
PremiumCompany Announcements
Lexaria Bioscience Shareholders Endorse Directors and Auditors
3M ago
8K
LEXX
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
PremiumCompany Announcements
Lexaria Adds Six Global Patents, Reaches 60 Granted as It Rallies Shareholders Ahead of 2026 Meeting
3M ago
LEXX
Lexaria Bioscience awarded six additional patents
PremiumThe Fly
Lexaria Bioscience awarded six additional patents
3M ago
LEXX
Lexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
PremiumCompany AnnouncementsLexaria Deepens GLP-1 Focus With DehydraTECH Advances, Patents and Fresh Capital
4M ago
LEXX
Lexaria CEO says ‘closer to a commercial breakthrough than ever before’
Premium
The Fly
Lexaria CEO says ‘closer to a commercial breakthrough than ever before’
4M ago
LEXX
Lexaria’s Phase 1b GLP-1 Study Shows Comparable Metabolic Outcomes and Encouraging Blood Pressure Data for DehydraTECH Platform
Premium
Company Announcements
Lexaria’s Phase 1b GLP-1 Study Shows Comparable Metabolic Outcomes and Encouraging Blood Pressure Data for DehydraTECH Platform
4M ago
LEXX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >